Metzger Michael A
Chief Executive Officer
Sale 10b5-1
- Shares
- 32,375
- Price
- $24.24
- Value
- $784,776
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•19 filings
SNDX
Syndax Pharmaceuticals Inc
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$1,968,419
2 distinct insiders
Highlighted alerts
0
7 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get SNDX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SNDX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
46
Raw transactions
Everything returned by the filing
7
Voluntary view
P/S trades after deterministic checks
37
Administrative noise
Stored, never alerted
22
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 1,177
- Price
- $18.99
- Footnotes
- 1
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Botwood Nicholas A.J.
Head of R&D, CMO
Sale 10b5-1
- Shares
- 31,235
- Price
- $18.14
- Value
- $566,603
Botwood Nicholas A.J.
Head of R&D, CMO
Sale 10b5-1
- Shares
- 34,280
- Price
- $18.00
- Value
- $617,040
Metzger Michael A
Chief Executive Officer
Sale 10b5-1
- Shares
- 157,307
- Price
- $16.41
- Value
- $2,582,021
Podlesak Dennis
Director
Sale 10b5-1
- Shares
- 19,200
- Price
- $15.84
- Value
- $304,170
Podlesak Dennis
Director
Sale 10b5-1
- Shares
- 19,200
- Price
- $15.54
- Value
- $298,408
Podlesak Dennis
Director
Sale 10b5-1
- Shares
- 19,200
- Price
- $14.19
- Value
- $272,521
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 08, 2026 | Metzger Michael A Chief Executive Officer | Sale | 32,375 | $24.24 | $784,776 | |
| Jun 12, 2026 | Botwood Nicholas A.J. Head of R&D, CMO | Sale | 31,235 | $18.14 | $566,603 | |
| Jun 11, 2026 | Botwood Nicholas A.J. Head of R&D, CMO | Sale | 34,280 | $18.00 | $617,040 | |
| Sep 08, 2025 | Metzger Michael A Chief Executive Officer | Sale | 157,307 | $16.41 | $2,582,021 | |
| Aug 18, 2025 | Podlesak Dennis Director | Sale | 19,200 | $15.84 | $304,170 | |
| Aug 15, 2025 | Podlesak Dennis Director | Sale | 19,200 | $15.54 | $298,408 | |
| Aug 14, 2025 | Podlesak Dennis Director | Sale | 19,200 | $14.19 | $272,521 |